Charter

Since its inception, Eris Pharmaceuticals has strived in delivering:

  • A quality-oriented portfolio of Branded Generics approved by the TGA (Therapeutic Goods Administration – Australia)
  • Qualitative Dermo-cosmetic, Medical Devices, and OTC  products
  • Personalised approach to each market, delivering unique proposals for successful introduction and expansion
  • Development of strong synergies with highly ranked companies, bringing innovative & niche products to the markets.
     

The scope in Eris Pharmaceuticals’ approach is setup in such way that it:

  • Provides premium branded pharmaceutical products to patients
  • Distributes products efficiently, effectively and at a price that will positively influence the health and welfare of patients
  • Makes a genuine contribution towards the improvement of healthcare practices
  • Utilises our extensive regional knowledge and focus on local relationships to build a cultural bridge for business success in the markets where Eris Pharmaceuticals is present.
Back To Top

Related Links

Australian Business Unit

The Australian Business Unit covers the needs of the Australian & New Zealand markets.

Learn more »

Overseas Business Unit

The Overseas Business Unit covers the activities and needs of the Emerging markets.

Learn more »

Life in Focus™

Discover Life in Focus™, the new range in Dietary Supplements.

Learn more »